Nucleoside transporters: from scavengers to novel therapeutic targets

Trends Pharmacol Sci. 2006 Aug;27(8):416-25. doi: 10.1016/ Epub 2006 Jul 3.


Hydrophilic purine and pyrimidine nucleosides rely on specialized carrier proteins for their membrane translocation. The recent identification of two gene families encoding equilibrative and concentrative nucleoside transporters in mammals and other organisms has provided the essential breakthrough to a more complete understanding of the biological significance of nucleoside transport. Although nucleoside salvage is a primary function of these proteins, recent data indicate functions beyond metabolic recycling. In brain and spinal cord, for example, nucleoside transporters have the potential to regulate synaptic levels of neuroactive purines such as adenosine and, thereby, indirectly modulate physiological processes through G-protein-coupled purine P1 receptors. As described in this review, recent research indicates novel putative functions for CNS nucleoside transporters in sleep, arousal, drug and alcohol addiction, nociception and analgesia. The therapeutic use of nucleoside analogue drugs and nucleoside transporter inhibitors in viral, neoplastic, cardiovascular and infectious disease is also described.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Humans
  • Models, Biological
  • Molecular Structure
  • Nucleoside Transport Proteins / antagonists & inhibitors
  • Nucleoside Transport Proteins / physiology*
  • Pharmaceutical Preparations / administration & dosage*
  • Pharmaceutical Preparations / chemistry


  • Nucleoside Transport Proteins
  • Pharmaceutical Preparations